These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2985390)
1. Concentration of 99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatomas. Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Tanaka S; Kasugai H; Okano Y Eur J Nucl Med; 1985; 10(5-6):255-8. PubMed ID: 2985390 [TBL] [Abstract][Full Text] [Related]
2. Comparison of delayed hepatobiliary imaging using 99mTc-Sn-N-pyridoxyl-5-methyltryptophan and 67Ga-citrate imaging for diagnosis of hepatocellular carcinoma. Hasegawa Y; Nakano S; Ishiguro S; Imaoka S; Sasaki Y; Tanaka S; Kasugai H; Kojima J; Ishigami S Eur J Nucl Med; 1988; 14(7-8):414-8. PubMed ID: 2846309 [TBL] [Abstract][Full Text] [Related]
3. Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging. Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Sasaki Y; Imaoka S; Fujita M; Kawamoto S; Kasugai H Cancer; 1986 Jan; 57(2):230-6. PubMed ID: 2417674 [TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in diagnosis of hepatoma]. Hasegawa Y; Nakano S; Noguchi A; Hashizume T; Ibuka K; Sasaki Y; Imaoka M; Kozima J; Ishigami S Kaku Igaku; 1983 Nov; 20(9):1355-9. PubMed ID: 6328071 [No Abstract] [Full Text] [Related]
5. Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis. Hasegawa Y; Nakano S; Hiyama T; Sobue T; Yoshida H; Sasaki Y; Imaoka S; Inoue A; Tanaka S; Kusagai H J Nucl Med; 1991 Feb; 32(2):228-35. PubMed ID: 1846910 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in the diagnosis of intrahepatic masses. Oyamada H; Yamazaki S; Makuuchi M; Hasegawa H Radioisotopes; 1989 May; 38(5):244-51. PubMed ID: 2546192 [TBL] [Abstract][Full Text] [Related]
7. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent. Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618 [TBL] [Abstract][Full Text] [Related]
8. Small hepatocellular carcinoma visualized with technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan. Narabayashi I; Hamada T; Aoki O; Suematsu T Ann Nucl Med; 1987 Sep; 1(1):39-42. PubMed ID: 2856317 [TBL] [Abstract][Full Text] [Related]
9. [Scintigraphy using 99mTc-PMT, 99mTc-DEIDA, or 67Ga--detection of hepatocellular carcinoma and its metastasis]. Hasegawa Y; Nakano S Nihon Rinsho; 1991 Aug; 49(8):1858-62. PubMed ID: 1664892 [No Abstract] [Full Text] [Related]
11. A new synthetic method for 99mTc labeled N-pyridoxyl-5-methyltryptophan as a hepatoma imaging agent. Zhou YG; Zhu T; Zhao HY; Wu ZM; Shi QX; Liang FH Int J Rad Appl Instrum B; 1987; 14(5):467-73. PubMed ID: 2822632 [TBL] [Abstract][Full Text] [Related]
12. [Experimental and clinical studies of hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyltryptophan(99mTc-PMT)]. Yoshida H; Kanamori I; Nakano S; Takeda I; Yasuda E; Matsuo S; Ichikawa H; Kimura T; Iwata F; Higuchi C Radioisotopes; 1983 Jul; 32(7):340-43. PubMed ID: 6658021 [No Abstract] [Full Text] [Related]
13. Hepatobiliary scintigraphy and function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTC-PMT). Sugimura K; Nishiyama S; Narabayashi I Kobe J Med Sci; 1985 Apr; 31(2):85-94. PubMed ID: 4021432 [No Abstract] [Full Text] [Related]
14. Analysis of factors affecting uptake of Tc-99m Sn-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma. Hasegawa Y; Nakano S; Sobue T; Fujita M; Ishiguro S; Sasaki Y; Imaoka S; Tanaka S; Kasugai H; Inoue A Ann Nucl Med; 1994 May; 8(2):139-45. PubMed ID: 7521195 [TBL] [Abstract][Full Text] [Related]
15. Extraosseous metastases of hepatocellular carcinoma detection and therapeutic assessment with Tc-99m PMT SPECT. Hayase N; Fukumoto M; Yoshida D; Kariya S; Akagi N; Kurohara A; Hisa N; Yoshida S Clin Nucl Med; 1999 May; 24(5):326-9. PubMed ID: 10232470 [TBL] [Abstract][Full Text] [Related]
16. [Radionuclear estimation with 99mTc-N-pyridoxyl-5-methyl-tryptophan (PMT) scintigraphy of recurrent hepatocellular carcinoma after non-surgical treatment]. Matsumoto H; Matsuura M; Sakurai H; Nakajima N; Ito K Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Oct; 57(12):805-11. PubMed ID: 9394570 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of 99mTc-PMT delayed imaging in diagnosis of hepatocellular carcinoma]. Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Kasugai H; Tanaka S; Inoue A; Kojima J; Fujita M Kaku Igaku; 1992 Mar; 29(3):367-76. PubMed ID: 1316500 [TBL] [Abstract][Full Text] [Related]
18. [Hepatobiliary scintigraphy and liver function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT)]. Sugimura K; Narabayashi I; Nabeshima K; Ishido N; Hashimoto K; Yamasaki K; Hamada T; Sugimura C; Suematsu T; Inoue Y Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1205-13. PubMed ID: 6672750 [No Abstract] [Full Text] [Related]
19. Accumulation of 99mTc-PMT in renal metastasis of hepatocellular carcinoma. Shiozaki T; Hayakawa K; Tanikake M; Oida T; Hida S; Yasui H; Urata Y; Tanaka A; Morimoto T Ann Nucl Med; 2003 Jun; 17(4):333-6. PubMed ID: 12932119 [TBL] [Abstract][Full Text] [Related]
20. A hepatobiliary study with Tc-99m N-pyridoxyl-5-methyltryptophan (PMT) in a patient with hepatoblastoma. Ohshiro K; Hanashiro Y; Shimabukuro K; Hori A; Nagata Y; Matsumoto H; Uchima H Clin Nucl Med; 1991 Jan; 16(1):10-2. PubMed ID: 1847848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]